BerGenBio is an oncology biotech company that develops medicines to treat cancer. The Company develops immuno-oncology drugs, inhibitors, and therapeutics. It also develops clinical trial programmes which focuse on treatment of non-small lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as melanoma and triple negative breast cancer.